Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:833

Official publication of the Indian Society of Nephrology
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy

Jairam A, Das R, Aggarwal P K, Kohli H S, Gupta K L, Sakhuja V, Jha V

Year : 2010| Volume: 20| Issue : 3 | Page no: 125-131

   This article has been cited by
 
1 Iron metabolism and management: focus on chronic kidney disease
Anil K. Agarwal
Kidney International Supplements. 2021; 11(1): 46
[Pubmed]  [Google Scholar] [DOI]
2 Effect of hepcidin antagonists on anemia during inflammatory disorders
Poonam Sagar, Stanzin Angmo, Rajat Sandhir, Vikas Rishi, Hariom Yadav, Nitin Kumar Singhal
Pharmacology & Therapeutics. 2021; 226: 107877
[Pubmed]  [Google Scholar] [DOI]
3 Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD)
Peiyuan Li, Chenqi Xia, Peng Liu, Zhong Peng, Hong Huang, Juan Wu, Zhangxiu He
BMC Nephrology. 2020; 21(1)
[Pubmed]  [Google Scholar] [DOI]
4 The Influence of Inflammation on Anemia in CKD Patients
Anna Gluba-Brzůzka, Beata Franczyk, Robert Olszewski, Jacek Rysz
International Journal of Molecular Sciences. 2020; 21(3): 725
[Pubmed]  [Google Scholar] [DOI]
5 Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin
Zhian Sherzad Hayder, Zrar Saleem Kareem
International Urology and Nephrology. 2020; 52(4): 749
[Pubmed]  [Google Scholar] [DOI]
6 Study of hepcidin level in patients with chronic kidney disease and its correlation with markers of iron status in Zagazig University Hospital
Nafesa M. Kamal, Magda Diab, Rania A. Khalil
The Egyptian Journal of Internal Medicine. 2018; 30(4): 284
[Pubmed]  [Google Scholar] [DOI]
7 Iron status in patients with chronic heart failure
E. A. Jankowska,J. Malyszko,H. Ardehali,E. Koc-Zorawska,W. Banasiak,S. von Haehling,I. C. Macdougall,G. Weiss,J. J. V. McMurray,S. D. Anker,M. Gheorghiade,P. Ponikowski
European Heart Journal. 2013; 34(11): 827
[Pubmed]  [Google Scholar] [DOI]
8 Noninvasive assessment of bone health in Indian patients with chronic kidney disease
Jabbar, Z. and Aggarwal, P.K. and Chandel, N. and Khandelwal, N. and Kohli, H.S. and Sakhuja, V. and Jha, V.
Indian Journal of Nephrology. 2013; 23(3): 161-167
[Pubmed]  [Google Scholar]
9 Acute and sub-acute effect of ferric carboxymaltose on inflammation and adhesion molecules in patients with predialysis chronic renal failure [Efecto agudo y subagudo de la carboximaltosa férrica sobre la inflamación y moléculas de adhesión en pacientes con insuficiencia renal crónica prediálisis]
Prats, M. and Font, R. and Garc√≠a-Ruiz, C. and Cabr√©, C. and Mu√Īoz-Cort√©s, M. and Rosa Nogu√©s, M. and Jariod, M. and Romeu, M. and Mart√≠nez-Vea, A.
Nefrologia. 2013; 33(3): 355-361
[Pubmed]  [Google Scholar]
10 Hepcidin and iron metabolism disorders in patients with chronic kidney disease [Hepcidin i poremecaji metabolizma gvoŇĺda kod bolesnika sa hronicnom bubreŇĺnom boleŇ°cu]
Jelic, M. and Cvetkovic, T. and Djordjevic, V. and Damnjanovic, G. and Vlahovic, P. and Kocic, G. and Djindjic, N. and Jovovic, B. and Antic, A.
Vojnosanitetski Pregled. 2013; 70(4): 368-373
[Pubmed]  [Google Scholar]
11 Iron status in patients with chronic heart failure
Jankowska, E.A. and Malyszko, J. and Ardehali, H. and Koc-Zorawska, E. and Banasiak, W. and Von Haehling, S. and MacDougall, I.C. and Weiss, G. and McMurray, J.J.V. and Anker, S.D. and Gheorghiade, M. and Ponikowski, P.
European Heart Journal. 2013; 34(11): 827-834
[Pubmed]  [Google Scholar]
12 Cytotoxic CD4+CD28null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease
Yadav, A.K. and Lal, A. and Jha, V.
Nephron - Clinical Practice. 2012; 120(4): c185-c193
[Pubmed]  [Google Scholar]
13 Association between serum neopterin and inflammatory activation in chronic kidney disease
Yadav, A.K. and Sharma, V. and Jha, V.
Mediators of Inflammation. 2012; 2012(476979)
[Pubmed]  [Google Scholar]
14 Association between Serum Neopterin and Inflammatory Activation in Chronic Kidney Disease
Ashok Kumar Yadav,Vinod Sharma,Vivekanand Jha
Mediators of Inflammation. 2012; 2012: 1
[Pubmed]  [Google Scholar] [DOI]
15 Cytotoxic CD4+CD28null T Lymphocytes, Systemic Inflammation and Atherosclerotic Risk in Patients with Chronic Kidney Disease
Ashok Kumar Yadav,Anupam Lal,Vivekanand Jha
Nephron Clinical Practice. 2012; 120(4): c185
[Pubmed]  [Google Scholar] [DOI]
16 CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis
A. K. Yadav,V. Jha
Nephrology Dialysis Transplantation. 2011; 26(5): 1689
[Pubmed]  [Google Scholar] [DOI]
17 Association of circulating fractalkine (CX3CL1) and CX3CR1 +CD4 + T cells with common carotid artery intima-media thickness in patients with chronic kidney disease
Yadav, A.K., Lal, A., Jha, V.
Journal of Atherosclerosis and Thrombosis. 2011; 18(11): 958-965
[Pubmed]  [Google Scholar]
18 CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis
Yadav, A.K., Jha, V.
Nephrology Dialysis Transplantation. 2011; 26(5): 1689-1694
[Pubmed]  [Google Scholar]
19 Iron status in ESRD patients
Wiwanitkit, V.
Indian Journal of Nephrology. 2011; 21(1): 67-68
[Pubmed]  [Google Scholar]

 

© Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07